用于持久癌症免疫治疗的隐形生物粘合能力的可分离纳米疫苗
1School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, P. R. China.
Journal of the American Chemical Society
|March 17, 2023
概括
这项研究引入了一种基于生物粘合纳米粒子 (BNP) 的新型癌症疫苗FeSHK@B-ovalbumin (OVA),旨在克服瘤防御并增强免疫疗法. 这种纳米疫苗有效地触发了强大的,持久的抗瘤免疫和免疫记忆.
科学领域:
- 生物技术
- 免疫学
- 材料科学
背景情况:
- 癌症疫苗通常由于瘤异质性和免疫抑制微环境而失败.
- 开发有效的癌症免疫疗法仍然是一个重大挑战.
研究的目的:
- 开发一种基于生物粘合纳米粒子 (BNP) 的可分离癌症疫苗,FeSHK@B-ovalbumin (OVA).
- 针对多层抗原并诱导有效的癌症免疫疗法.
- 克服目前癌症疫苗在引起强大的抗瘤反应方面的局限性.
主要方法:
- 设计了一个"纳米火箭"系统 (FeSHK@B-OVA) 在酸性瘤微环境中进行分离.
- 使用FeSHK@B"发射器"诱导氧化应激和免疫细胞死亡.
- 延长药物保留和抗原储存的提高生物粘合性.
- 研究了FeSHK@B组件和OVA"卫星"对免疫激活的协同作用.
主要成果:
- 在体内,FeSHK@B-OVA纳米疫苗有效抑制了原发性瘤的生长.
- 诱导耐用,抗原特异性免疫激活和长期免疫记忆.
- 成功抵制瘤复发和转移.
- 将原发性瘤转化为抗原库, 增强免疫疗法.
结论:
- 作为治疗和预防癌症的纳米疫苗,FeSHK@B-OVA具有显著的潜力.
- 这种生物粘合纳米疫苗策略为开发多种癌症疫苗提供了直接的方法.
- 在位抗原储存和多表位协同作用的结合增强了抗瘤免疫力.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
799
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.3K
相关概念视频
01:30Cancer Vaccines
460
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
460
01:27Tumor Immunotherapy
601
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
601